American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$250M |
| 2 |
Workday
WDAY
|
+$183M |
| 3 |
Apple
AAPL
|
+$178M |
| 4 |
Eli Lilly
LLY
|
+$172M |
| 5 |
GE Vernova
GEV
|
+$159M |
Top Sells
| 1 |
Visa
V
|
+$494M |
| 2 |
Colgate-Palmolive
CL
|
+$234M |
| 3 |
NXP Semiconductors
NXPI
|
+$184M |
| 4 |
Duke Energy
DUK
|
+$176M |
| 5 |
Intuitive Surgical
ISRG
|
+$166M |
Sector Composition
| 1 | Technology | 26.52% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 11.51% |
| 4 | Healthcare | 11.16% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
ESAB
ESAB
$6.69B
| $699K | ﹤0.01% |
6,573
-2,322
| -26% | -$247K |
|
2352
C4 Therapeutics
CCCC
$189M
| $698K | ﹤0.01% |
122,373
+12,298
| +11% | +$70.1K |
|
2353
Consumer Portfolio Services
CPSS
$190M
| $696K | ﹤0.01% |
74,162
| – | – |
|
2354
TeraWulf
WULF
$4.39B
| $690K | ﹤0.01% |
147,437
+18,595
| +14% | +$87K |
|
2355
monday.com
MNDY
$9.9B
| $689K | ﹤0.01% |
2,481
+149
| +6% | +$41.4K |
|
2356
Virtu Financial
VIRT
$3.1B
| $689K | ﹤0.01% |
22,607
+937
| +4% | +$28.5K |
|
2357
Twin Disc
TWIN
$190M
| $688K | ﹤0.01% |
+55,110
| New | +$688K |
|
2358
Tejon Ranch
TRC
$448M
| $684K | ﹤0.01% |
38,964
+6,738
| +21% | +$118K |
|
|
SHYF
2359
DELISTED
The Shyft Group
SHYF
| $678K | ﹤0.01% |
54,019
+14,018
| +35% | +$176K |
|
|
NXDR
2360
Nextdoor Holdings
NXDR
$805M
| $678K | ﹤0.01% |
273,348
+83,201
| +44% | +$206K |
|
2361
Grab
GRAB
$24.5B
| $677K | ﹤0.01% |
178,227
| – | – |
|
2362
Zebra Technologies
ZBRA
$15.9B
| $677K | ﹤0.01% |
1,827
-1,435
| -44% | -$531K |
|
2363
Anika Therapeutics
ANIK
$125M
| $675K | ﹤0.01% |
27,338
+3,446
| +14% | +$85.1K |
|
2364
BankFinancial
BFIN
$153M
| $667K | ﹤0.01% |
54,737
-266
| -0.5% | -$3.24K |
|
2365
Adtran
ADTN
$809M
| $665K | ﹤0.01% |
112,115
+21,772
| +24% | +$129K |
|
2366
Voyager Therapeutics
VYGR
$232M
| $664K | ﹤0.01% |
113,536
-905,796
| -89% | -$5.3M |
|
2367
Excelerate Energy
EE
$770M
| $661K | ﹤0.01% |
30,034
-440,044
| -94% | -$9.69M |
|
2368
Perrigo
PRGO
$3.06B
| $660K | ﹤0.01% |
25,172
+838
| +3% | +$22K |
|
2369
American Century Select High Yield ETF
AHYB
$46.8M
| $660K | ﹤0.01% |
14,148
-39,992
| -74% | -$1.87M |
|
2370
iRadimed
IRMD
$907M
| $653K | ﹤0.01% |
12,993
+2,588
| +25% | +$130K |
|
2371
Fate Therapeutics
FATE
$111M
| $649K | ﹤0.01% |
185,409
+19,154
| +12% | +$67K |
|
2372
Ocular Therapeutix
OCUL
$2.23B
| $648K | ﹤0.01% |
+74,491
| New | +$648K |
|
2373
Astronics
ATRO
$1.41B
| $648K | ﹤0.01% |
33,265
+7,061
| +27% | +$138K |
|
2374
Kura Oncology
KURA
$711M
| $647K | ﹤0.01% |
33,094
-9,518
| -22% | -$186K |
|
2375
NewtekOne
NEWT
$303M
| $646K | ﹤0.01% |
51,882
-138,830
| -73% | -$1.73M |
|